CORC

浏览/检索结果: 共139条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H 期刊论文
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61
作者:  Guo, Huihui;  Zhang, Xilin;  Xie, Shangzhi;  Chen, Tianwei;  Xie, Dong
收藏  |  浏览/下载:22/0  |  提交时间:2022/12/22
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Jin, Ying;  Lin, Chen;  Shi, Xun;  He, Qiong;  Yan, Junrong
收藏  |  浏览/下载:21/0  |  提交时间:2022/12/23
Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs) 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2021
作者:  Si, Jinfei;  Gu, Xiaodong;  Wang, Wenxian;  Ying, Shenpeng;  Song, Zhengbo
收藏  |  浏览/下载:60/0  |  提交时间:2022/02/14
Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026
作者:  Shi, Yuankai;  Zhang, Shucai;  Hu, Xingsheng;  Feng, Jifeng;  Ma, Zhiyong
收藏  |  浏览/下载:39/0  |  提交时间:2020/12/24
Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun
收藏  |  浏览/下载:21/0  |  提交时间:2020/10/26
BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR(T790M) mutation 期刊论文
THERANOSTICS, 2020, 卷号: 10, 期号: 14, 页码: 6122-6135
作者:  Yin, Weimin;  Zhao, Yuge;  Kang, Xuejia;  Zhao, Pengfei;  Zhao, Xuhong
收藏  |  浏览/下载:44/0  |  提交时间:2020/07/01
EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC 期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 页码: 15
作者:  Qin, Jianhua;  Liu, Yang;  Yin, Yalei;  Sun, Mingju;  Zhan, Xi
收藏  |  浏览/下载:107/0  |  提交时间:2019/06/20
Egfr signaling confers resistance to bet inhibition in hepatocellular carcinoma through stabilizing oncogenic myc 期刊论文
Journal of experimental & clinical cancer research, 2019, 卷号: 38, 页码: 15
作者:  Yin, Yalei;  Sun, Mingju;  Zhan, Xi;  Wu, Changqing;  Geng, Pengyu
收藏  |  浏览/下载:137/0  |  提交时间:2019/05/08
Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib A case report 期刊论文
MEDICINE, 2019, 卷号: 98, 期号: 1
作者:  Cai, Yangyang;  Wang, Xu;  Guo, Ye;  Sun, Chao;  Xu, Yinghui
收藏  |  浏览/下载:28/0  |  提交时间:2019/12/05
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China 期刊论文
LUNG CANCER, 2019, 卷号: 127
作者:  Gu, Xiaohua;  Zhang, Qiang;  Chu, Yun-Bo;  Zhao, Yi-Yang;  Zhang, Yan-Jun
收藏  |  浏览/下载:14/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace